Saturday, January 30, 2010

9 Upcoming Tablet Alternatives to the Apple iPad

The Apple iPad cat is officially out of its bag, but it’s not going to be the only tablet game in town. There are a number of other devices out there in various stages from “barely announced” to “working prototype,” many of which were shown off at this year’s Consumer Electronics Show.

Apple may have snagged first-mover advantage in this year’s tablet renaissance, and we have scant few details on things like pricing and release date for some of its upcoming competitors. Still, it’s worth a look at what other tablet contenders are going to be emerging with in the near near future. It might be worth reigning in that Steve Jobs-induced credit card trigger finger for a bit.

Let’s have a look at what alternatives to the iPad are likely literally just around the corner.

http://mashable.com/2010/01/27/9-upcoming-tablet-alternatives-to-the-apple-ipad/

Wednesday, January 27, 2010

Apple IPad ... Jesus

Monday, January 25, 2010

MusicDNA pode vir a ser o herdeiro directo do mp3


O grande sucessor do mp3 já tem nome: MusicDNA. A grande inovação do formato é disponibilizar, a par com a música, outro tipo de material, tal como fotografias, letras de canções e calendário de espectáculos. Só há uma condição: que a música tenha sido descarregada de forma legal.

[@From : http://www.publico.clix.pt/Tecnologia/musicdna-pode-vir-a-ser-o-herdeiro-directo-do-mp3_1419526 on Mon Jan 25 2010 11:53:10 GMT+0000 (GMT Standard Time)]

Thursday, January 21, 2010

Wednesday, January 13, 2010

I.B.M. Joins Pursuit of $1,000 Personal Genome

By JOHN MARKOFF
Published: October 5, 2009

One of the oldest names in computing is joining the race to sequence the genome for $1,000. On Tuesday, I.B.M. plans to give technical details of its effort to reach and surpass that goal, ultimately bringing the cost to as low as $100, making a personal genome cheaper than a ticket to a Broadway play.
The project places I.B.M. squarely in the middle of an international race to drive down the cost of gene sequencing to help move toward an era of personalized medicine. The hope is that tailored genomic medicine would offer significant improvements in diagnosis and treatment.
Continue reading here: http://www.nytimes.com/2009/10/06/science/06dna.html?_r=2&scp=3&sq=markoff%20&st=cse

Sunday, January 03, 2010

Saturday, January 02, 2010